key: cord-0850185-5wyldvre
authors: Björck, Martin; Boyle, Jonathan R.; Dick, Florian
title: The Need of Research Initiatives Amidst and After the Covid-19 Pandemic: A Message from the Editors of the European Journal of Vascular and Endovascular Surgery
date: 2020-04-10
journal: Eur J Vasc Endovasc Surg
DOI: 10.1016/j.ejvs.2020.04.002
sha: df070f77fd0f09694601a589a188798f2b93e66e
doc_id: 850185
cord_uid: 5wyldvre

nan

We write this editorial while many are facing the greatest turmoil within healthcare since the Second World War. Covid-19 impacts our patients, ourselves, and our profession in many different ways. For instance, never before have the advantages of minimally invasive possibilities been more obvious.

Even major aortic surgery can be performed without a need for intensive care in many cases.

Between 1999 and 2013, the proportion of patients who needed less than 48 hours of intensive care after abdominal aortic aneurysm (AAA) repair decreased from 41% to 7%, whereas the use of endovascular aortic repair (EVAR) increased from 7% to 78%. 1 EVAR is also established as the first line The importance of research, and of the unique research opportunities that this situation presents, must not be overlooked amid these challenges. The consequences of the Covid-19 pandemic will affect vascular surgery worldwide for a long time period, and probably longer than expected now. Many of the postponed elective and semi-acute operations will have to be performed later on, in a secondary overwhelming wave of challenges. Paradoxically, a high death toll among the oldest in our populations may somewhat reduce the need of vascular surgery, and counteract this effect.

There are many unanswered questions, such as: What impact do different stages of Covid-19 have on surgical outcomes? Does type of surgery and anaesthesia affect these outcomes, both in the short and long term? What is the risk for surgeons, nurses, assistants, and anaesthesiologists? What protective measures are effective? What collateral damage (in terms of missed treatment opportunities and options for other patients) does Covid-19 bring, and how can this best be confronted? Scientists must design appropriate studies now to be able to answer such questions later. After all, this will not be the last pandemic affecting the human population and our specialty.

According to epidemiologists minor pandemics tend to occur every 20 years, and major ones every 100 years.

The easiest, fastest, and probably most effective way to ensure that we will be able to answer these and other questions in the future is to use the already established quality improvement registries, for instance the Vascunet and International Consortium of Vascular Registries collaborations. 3 To add the simple pre-operative variable, identifying if the patient is Sars-cov-2 positive or not (or if status is unknown), would already allow later analyses of how the outcome was affected after adjustments for potential confounding. 4 It would also be interesting to add this The Covid-19 pandemic presents vascular surgeons with the opportunity to study many fundamental issues facing our specialty. While we did not ask for this turmoil, even the most devastating cyclone has a windless eye. One major drawback of the vascular registries in this particular situation is the fact that most of them only register patients who were operated on.

Multicentre international collaborations, merging complete datasets from multiple institutions who could start to collect data on patients whose operations were postponed, could help us to answer these outstanding issues.

It is easy to identify the negative aspects of globalisation, when the Covid-19 epidemic spread so quickly. We must remember, however, that the Chinese characterisation of the virus RNA sequence, and the German development of the first polymerase chain reaction diagnostic tool, also spread globally, and much faster. The global scientific community has stood up to the highest standards. Unfortunately, the same cannot be said for the organisation of healthcare. Many hospitals and countries struggle with shortages of drugs, ventilators, and personal protective equipment, putting both patients and staff at risk. Given the regular frequency with which infective epidemics have haunted humanity throughout history, the verdict on those responsible may be harsh.

The EJVES is an important player in the vascular scientific community, and we are committed to play our part in this difficult situation. We would like to highlight our fast track publication possibilities to enable fast, yet scientifically sound, communication when indicated. For instance, we recently published an important paper about the paclitaxel debate fast track. 9 The paper was Take care of your patients, your staff, your families, but also of yourselves in this difficult situation. The secret of winning a war is -in the middle of the fight -to prepare for the next battle.

The outcome will depend on how much we are willing to learn from the current challenges.

Editor's Choice -Prolonged ICU length of stay after AAA repair: Analysis of time trends and long term outcome

European Society for Vascular Surgery (ESVS) 2019 clinical practice guidelines on the management of abdominal aorto-iliac artery aneurysms

International Consortium of Vascular Registries -Unique collaborations for quality improvement in vascular surgery

Alternatives to randomised controlled trials for the poor, the impatient and when evaluating emerging technologies

United Kingdom Small Aneurysm Trial Participants

Long-term outcomes of immediate repair compared with surveillance of small abdominal aortic aneurysms

Safety of men with small and medium abdominal aortic aneurysms under surveillance in the NAAASP

Meta-analysis of individual patient data to examine factors affecting growth and rupture of small abdominal aortic aneurysms

Joint guidelines of the Society for Vascular Surgery; European Society for Vascular Surgery; World Federation of Vascular Societies

Long term survival after femoropopliteal artery revascularisation with paclitaxel coated devices: A propensity score matched cohort analysis

Florian Dick c a Department of Surgical Sciences, Section of Vascular Surgery